Scinai Immunotherapeutics

(NASDAQ) SCNI

Current Price$0.71

Market Cap$2.46M

Since IPO (2015)-100%

5 Year-100%

1 Year-74%

1 Month+11%

Scinai Immunotherapeutics Financials at a Glance

Market Cap

$2.46M

Revenue (TTM)

$1.31M

Net Income (TTM)

$8.31M

EPS (TTM)

$-10.26

P/E Ratio

-0.07

Dividend

$0.00

Beta (Volatility)

0.99 (Low)

Dividend

$0.00

Beta (Volatility)

0.99 (Low)

Price

$0.71

Volume

129,026

Open

$0.69

Price

$0.71

Volume

129,026

Open

$0.69

Previous Close

$0.71

Daily Range

$0.68 - $0.74

52-Week Range

$0.45 - $6.18

Dividend

$0.00

Beta (Volatility)

0.99 (Low)

Price

$0.71

Volume

129,026

Open

$0.69

Previous Close

$0.71

Daily Range

$0.68 - $0.74

52-Week Range

$0.45 - $6.18

SCNI News

Why BiondVax Pharmaceuticals Stock Imploded Today

Prosper Junior BakinyOct 23, 2020

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Scinai Immunotherapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Amir Reichman, MBA

Website

www.scinai.com

Headquarters

Jerusalem, IL

SCNI Financials

Key Financial Metrics (TTM)

Gross Margin

-2%

Operating Margin

-6%

Net Income Margin

-6%

Return on Equity

-93%

Return on Capital

-75%

Return on Assets

-71%

Earnings Yield

-14.29%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.46M

Shares Outstanding

3.47M

Volume

129.03K

Avg. Volume

3.30M

Financials (TTM)

Gross Profit

$2.65M

Operating Income

$7.54M

EBITDA

$6.53M

Operating Cash Flow

$6.03M

Capital Expenditure

$24.00K

Free Cash Flow

$6.05M

Cash & ST Invst.

$1.66M

Total Debt

$2.27M

Scinai Immunotherapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$263.64K

+28.0%

Gross Profit

$1.38M

-727.5%

Gross Margin

-5.24%

N/A

Market Cap

$2.46M

N/A

Market Cap/Employee

$79.43K

N/A

Employees

N/A

Net Income

$2.05M

+7.9%

EBITDA

$3.19M

-91.5%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$606.00K

-210.8%

Accounts Receivable

$168.00K

+40.0%

Inventory

$0.00

N/A

Long Term Debt

$1.94M

+124.6%

Short Term Debt

$329.00K

-9.6%

Return on Assets

-71.45%

N/A

Return on Invested Capital

-75.11%

N/A

Free Cash Flow

$1.29M

+26.7%

Operating Cash Flow

$1.29M

+26.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ENVBEnveric Biosciences, Inc.

ENVBEnveric Biosciences, Inc.$3.99+1.01%

ONCOOnconetix, Inc.

ONCOOnconetix, Inc.$0.64-8.57%

INDPIndaptus Therapeutics, Inc.

INDPIndaptus Therapeutics, Inc.$2.14-23.57%

REVBRevelation Biosciences, Inc.

REVBRevelation Biosciences, Inc.$1.12-0.88%

SPRCSciSparc Ltd.

SPRCSciSparc Ltd.$7.91-9.81%

SLXNSilexion Therapeutics Ltd.

SLXNSilexion Therapeutics Ltd.$0.60-2.25%

PBMPsyence Biomedical Ltd.

PBMPsyence Biomedical Ltd.$6.25-5.16%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$99.62+0.05%

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.43+0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

Questions About SCNI

What is the current price of Scinai Immunotherapeutics?

Scinai Immunotherapeutics is trading at $0.71 per share.

What is the 52-week range for Scinai Immunotherapeutics?

Over the past 52 weeks, Scinai Immunotherapeutics has traded between $0.45 and $6.18.

How much debt does Scinai Immunotherapeutics have?

As of the most recent reporting period, Scinai Immunotherapeutics reported total debt of $2.27M.

How much cash does Scinai Immunotherapeutics have on hand?

Scinai Immunotherapeutics reported $1.81M in cash and cash equivalents in its most recent financial results.

What is Scinai Immunotherapeutics’s dividend yield?

Scinai Immunotherapeutics does not currently have a dividend yield.

Scinai Immunotherapeutics

Scinai Immunotherapeutics Financials at a Glance

SCNI News

Why BiondVax Pharmaceuticals Stock Imploded Today

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Scinai Immunotherapeutics

SCNI Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Scinai Immunotherapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SCNI

What is the current price of Scinai Immunotherapeutics?

What is the 52-week range for Scinai Immunotherapeutics?

How much debt does Scinai Immunotherapeutics have?

How much cash does Scinai Immunotherapeutics have on hand?

What is Scinai Immunotherapeutics’s dividend yield?

Premium Investing Services